Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High
- August 14, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Ltd. Share Price stood at Rs 3,659, up 1.19% today, after touching a fresh 52-week high of Rs 3,698. The company’s market capitalisation stood at Rs 44,269.23 crore.
Ajanta Pharma Ltd. Share Price was at Rs 3,659 on 14 August 2026, up Rs 43 or 1.19% from the previous close of Rs 3,616, after the stock touched a fresh 52-week high of Rs 3,698 in intraday trade. With a market capitalisation of Rs 44,269.23 crore, the move has placed the stock in focus for investors tracking 52 Week High Stocks, Healthcare names and Stock Market Today developments.
The supplied data confirms the price event clearly: Ajanta Pharma Ltd. Share Price Today opened at Rs 3,616.4, moved within a day range of Rs 3,612.5 to Rs 3,698, and recorded turnover of Rs 1.74 crore on volume of 4,758 shares. That combination makes this a notable Share Price Update because a new one-year high often attracts attention from traders, long-term market watchers and those screening for Momentum Stocks or Market Movers.
What the verified data does not establish is a company-specific catalyst. In other words, Ajanta Pharma Ltd. Stock News today is driven by the confirmed price milestone itself rather than by any separately supplied earnings, corporate action or business update. For readers following Ajanta Pharma Ltd. Share Price Live, the key questions now shift to what today’s price action shows, how valuation metrics compare with the Healthcare benchmark, and where the stock sits relative to listed peers. Univest examines those points below using only the verified figures supplied for this event.
Ajanta Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,659 |
| Previous Close | Rs 3,616 |
| Today's Change | +Rs 43 (+1.19%) |
| Day Open | Rs 3,616.4 |
| Fresh 52-Week High | Rs 3,698 |
| Day Low | Rs 3,612.5 |
| Current Volume | 4,758 |
| Turnover | Rs 1.74 crore |
| Market Capitalisation | Rs 44,269.23 crore |
Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,659. versus the previous close of Rs 3,616, a rise of 1.19%. The stock opened at Rs 3,616.4, reached Rs 3,698, touched Rs 3,612.5. Reported volume was 4,758.
Ajanta Pharma Ltd. Share Price Today reflects a firm session in which the stock rose above its previous close and reached a fresh yearly high. The move was positive but not disorderly, with the stock opening near the previous close, holding above the intraday low and extending to a new 52-week peak.
In exact terms, Ajanta Pharma Ltd. Share Price opened at Rs 3,616.4 against a previous close of Rs 3,616. The stock then traded between Rs 3,612.5 and Rs 3,698 before standing at Rs 3,659, leaving it up by Rs 43 for the day. That translates into a gain of 1.19%, while the day high of Rs 3,698 also marked the fresh 52-week high and one-year high for the stock.
The intraday pattern matters. The open was almost unchanged from the prior close, which suggests the session did not begin with a large price gap. The low of Rs 3,612.5 was also close to the opening zone, while the subsequent climb to Rs 3,698 showed that buyers were willing to transact at higher levels during the session. Even though Ajanta Pharma Ltd. Share Price later eased from the day’s top to Rs 3,659, it still held above the previous close and remained near the upper end of the day’s range.
Turnover came in at Rs 1.74 crore with traded volume of 4,758 shares. On its own, that confirms participation in the move, though the supplied dataset does not include an average-volume benchmark for a deeper Volume Analysis. Still, within today’s Share Market Today context, the combination of a positive close-versus-previous-close setup and a fresh 52-week peak is enough to keep Ajanta Pharma Ltd. Share News on investor screens. From here, the next step is to examine whether the available fundamentals add support to the attention the stock is receiving on Univest.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 44,269.23 crore |
| P/E Ratio | 31.94x |
| P/B Ratio | 0.47x |
| ROE | -2.89% |
| ROCE | -0.26% |
Ajanta Pharma Ltd. was valued at a P/E ratio of 31.94x, a P/B ratio of 0.47x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.94x |
| Benchmark Median P/E | 21.38x |
| Benchmark Average P/E | 59.96x |
| Benchmark P/E Range | 0x to 3,299.57x |
| Company P/B Ratio | 0.47x |
| Benchmark Median P/B | 1.95x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 44,269.23 crore |
| Benchmark Median Market Cap | Rs 141.55 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 31.94x, which is above the benchmark median of 21.38x, a difference of +49.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,995.34 | 31.94 | 0.47 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,836.87 | 69.35 | 10.97 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,644.55 | 34.7 | 7.15 | -2.6 | 16.92 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,605.37 | 45.02 | 1.73 | -0.78 | 8.31 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,441.79 | 174.73 | 3.19 | 13.9 | 12.97 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 31.94x compared with the displayed peer median of 45.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 44,269.23 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma Ltd.
The stock is attracting attention because verified data places it at a fresh 52-week peak while also showing notable contrasts across valuation, size and profitability. For readers following Stocks in News, these are the main reasons it is being watched on Univest today.
- Fresh price milestone: Ajanta Pharma Ltd. Share Price touched Rs 3,698, its new 52-week high, and traded at Rs 3,659, up 1.19% or Rs 43 on the day.
- Defined intraday range: The stock opened at Rs 3,616.4, dipped to Rs 3,612.5 and climbed to the day’s high, indicating firm intraday Price Action.
- Participation data: Turnover stood at Rs 1.74 crore with traded volume of 4,758 shares.
- Large market value: The company’s market capitalisation of Rs 44,269.23 crore stands far above the supplied Healthcare benchmark figures.
- Mixed fundamentals: P/E is 31.94 and P/B is 0.47, while ROE of -2.89 and ROCE of -0.26 trail sector medians and several peers.
- Sector positioning: Within a 196-company Healthcare benchmark, the stock’s valuation is mixed and its size is unusually large versus the supplied comparison set.
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd. (AJANTPHARM) is presented in the supplied data as a listed company tracked within the Healthcare sector. In market terms, it is a sizeable participant, with a reported market capitalisation of Rs 44,269.23 crore, which places it far above the median and average company sizes shown in the same-sector benchmark.
For investors following Ajanta Pharma Ltd. NSE and Ajanta Pharma Ltd. BSE search intent, the company is currently in focus because its stock has reached a fresh one-year high. The current event says more about market activity and benchmark positioning than about a newly supplied business update, since the verified dataset here is centred on price, valuation, sector and peer figures. On Univest, that makes Ajanta Pharma Ltd. Share Price relevant for users looking at Stock Performance, sector placement and relative valuation within Healthcare.
Track Ajanta Pharma Ltd. Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Ajanta Pharma Ltd. Share Price can use Univest to follow live Share Price movements, 52-week levels, market capitalisation, valuation ratios, sector comparison and peer data in one place. Univest also helps users monitor Ajanta Pharma Ltd. Share Price Today alongside broader Market Trends, Stock Updates and company-level analytics.
For readers searching Ajanta Pharma Ltd. Stock News, Ajanta Pharma Ltd. Shareholding Pattern, Ajanta Pharma Ltd. Financial Results or Ajanta Pharma Ltd. Earnings, Univest provides a structured way to watch verified market data as it updates. In the context of today’s fresh 52-week high, the most relevant points to monitor next are whether the stock continues to hold near its new yearly high, how its valuation compares with the Healthcare benchmark, and whether future reported profitability trends change the current Fundamental Analysis picture.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Ajanta Pharma Ltd. Share Price today?
Ans. Ajanta Pharma Ltd. Share Price today was Rs 3,659 at the time of this update. The stock was up Rs 43, or 1.19%, from the previous close of Rs 3,616 after touching a fresh 52-week high.
Why is Ajanta Pharma Ltd. Share Price rising today?
Ans. The verified data confirms that Ajanta Pharma Ltd. Share Price rose as the stock hit a fresh 52-week high of Rs 3,698. However, the supplied dataset does not establish a separate company-specific catalyst for the move.
What is the fresh 52-week high of Ajanta Pharma Ltd.?
Ans. The fresh 52-week high of Ajanta Pharma Ltd. is Rs 3,698. The stock reached that intraday level on 14 August 2026 and later traded at Rs 3,659, still above the previous close of Rs 3,616.
How much did Ajanta Pharma Ltd. gain today?
Ans. Ajanta Pharma Ltd. gained Rs 43 today, which translates into a 1.19% rise over the previous close. The stock opened at Rs 3,616.4 and moved within an intraday band of Rs 3,612.5 to Rs 3,698.
What does today’s price action show for Ajanta Pharma Ltd.?
Ans. Today’s price action shows Ajanta Pharma Ltd. opening near the previous close, holding above the day’s low of Rs 3,612.5 and extending to a fresh yearly high of Rs 3,698 before trading at Rs 3,659.
What is Ajanta Pharma Ltd. market capitalisation?
Ans. Ajanta Pharma Ltd. had a market capitalisation of Rs 44,269.23 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 141.55 crore and average of Rs 465.17 crore.
Is Ajanta Pharma Ltd. expensive based on P/E?
Ans. Ajanta Pharma Ltd. trades at a P/E ratio of 31.94. That is above the Healthcare sector median of 21.38 but below the sector average of 59.96, which suggests a mixed valuation position.
How does Ajanta Pharma Ltd. compare on P/B ratio?
Ans. Ajanta Pharma Ltd. has a P/B ratio of 0.47 in the supplied data. That is below the Healthcare sector median of 1.95 and average of 2.63, placing it on the lower side of the benchmark distribution.
How do Ajanta Pharma Ltd. profitability ratios compare with the sector?
Ans. Ajanta Pharma Ltd. reports ROE of -2.89 and ROCE of -0.26. Both are below the Healthcare sector median values of 10.92 and 13.29, as well as the sector averages of 15.38 and 17.64.
Which peers are relevant for Ajanta Pharma Ltd. comparison?
Ans. The supplied peer set includes Dishman Carbogen Amcis, Beta Drugs, Dr Agarwals Eye Hospital, Ind-Swift Laboratories and Sai Parenteral's. Ajanta Pharma Ltd. is much larger by market capitalisation than each of these listed peers.
